pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
MIRUM · news · pharmadog
← back to MIRUM
News mentioning MIRUM
10
stories
13h
PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approval
biopharma dive
17h
AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll
biospace
2d
Mirum reports Phase 3 victory for acquired hepatitis D med
endpoints
2d
FDA nod for Mirum’s Atebrioz makes 3 options for ultra-rare bone disease
biospace
2d
Mirum posts phase 3 hepatitis win for ‘commercially differentiated’ challenger to Gilead, Vir
fiercebiotech
5d
FDA approves Mirum’s drug for ultra-rare soft tissue disease
endpoints
6d
Chutes & Ladders—Travere chief makes way for former Amicus CEO
fiercebiotech
20d
Chutes & Ladders—Longtime Takeda R&D chief to depart next June
fiercebiotech
Aug 20, 26
Regeneron wins FDA approval to challenge Ipsen for rare bone disease market
biospace
Jun 16, 26
Lilly buys another pain biotech; FDA sets decision for once-weekly PrEP pill
endpoints
